| 查看: 685 | 回复: 9 | ||
| 【奖励】 本帖被评价6次,作者ludasheng-1增加金币 5 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||
[资源]
Prodrugs: Challenges and Rewards, 2 Volume Set
|
||
![]() Publisher: Springer Number Of Pages: 1470 Publication Date: 2007-03-12 Sales Rank: 783734 ISBN / ASIN: 038749782X EAN: 9780387497822 Binding: Hardcover Manufacturer: Springer Studio: Springer Prodrugs are substances administered in an inactive form that is then metabolized in the body in vivo into the active compound. The rationale behind administering prodrugs is to optimize absorption, distribution, metabolism, and excretion of these drugs. Since first described in the 1950s, prodrugs continue to be a fertile area of research. There are a number of small pharmaceutical/biotech companies dedicated to using prodrugs for the delivery of older but problematic drugs as well as to developing broad-based prodrug technologies for application to new and future drugs. These volumes represent a comprehensive guide to prodrugs and will guide the reader through the current status of the prodrug concept and its many applications and to highlight its many successes in overcoming formulation and delivery of problematic drugs. http://rapidshare.com/files/51693440/Stel_PrChaRePa1BPA.rar |
» 猜你喜欢
211高校2026年入学博士名额
已经有16人回复
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
药理学论文润色/翻译怎么收费?
已经有162人回复
使用MolAICal生成小分子CHARMM力场拓扑和参数文件
已经有0人回复
二乙烯基砜的合成路径
已经有4人回复
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
求助!求美国食品化学药典内容:FCC13【低聚果糖专论】
已经有0人回复
【2027博士申请】纳米药物递送方向
已经有5人回复
消耗微量API,便可预测早期研发阶段的HME工艺可行性
已经有0人回复
反应液中苯酐除去
已经有1人回复
3楼2007-10-01 21:38:47
2楼2007-10-01 21:37:18










回复此楼
投票: